import img1 from "../../images/news_1.png";
import img2 from "../../images/news_2.png";
import img3 from "../../images/news_3.png";
import img4 from "../../images/news_4.png";
import img5 from "../../images/news_5.png";
import img6 from "../../images/news_6.jpg";

export const dataNews = [
  {
    image: img1,
    header: "Connecting the Dot for Success",
    headerBottom: "By Dr. Shlomo Sadounat November 21, 2021",
    description: `The business community’s new exercise that is taking over lately is “connecting the dot game”.`,
  },
  {
    image: img2,
    header: "ORPHELIA Pharma and K.S. KIM sign an agreement to supply Kigabeq®",
    headerBottom: "By Dr. Shlomo Sadounat November 16, 2021",
    description: `Paris and Tel Aviv – November 16th 2021 –ORPHELIA Pharma and K.`,
  },
  {
    image: img3,
    header: "Orphan Drugs - from Neglected Diseases to a Global Mission",
    headerBottom: "By Dr. Shlomo Sadounat November 13, 2021",
    description: `Orphan drugs impact about 7% of the global population, with 30M cases in the US and about 40M cases in Europe.`,
  },
  {
    image: img4,
    header: "Covid-19 Pandemic a Call for Action",
    headerBottom: "By Dr. Shlomo Sadounat July 31, 2021",
    description: `It’s almost August 2021, and we are 20 months into the Covid-19 pandemic that altered in so many ways.`,
  },
  {
    image: img5,
    header: "Mastering the Generic Pharmaceutical Distribution Sphere",
    headerBottom: "By Dr. Shlomo Sadounat April 24, 2021",
    description: `Many companies are applying various methodologies aiming to lead the generic pharmaceutical sphere.`,
  },
  {
    image: img6,
    header: "Israel MOH use DrugsIntel during the covid-19 pandemic",
    headerBottom: "By DrugsIntel Teamat July 14, 2020",
    description: `DrugsIntel to provide life saving insights DrugsIntel platform had proved to be extremely efficient during the covid19 pandemic outburst.`,
  },
];
